Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference bf026387ac
Drug names80First applicant · distinct drug namesAcceptance records156First applicant · distinct acceptance numbersUnder-review numbers36First applicant · current under-review listCo-applicant records0Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
156 acceptance records as first applicant, grouped into 80 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Imrecoxib Tablets 1 records · Latest accepted 2026/11/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602700 | Generic | 2026/11/05 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Flupentixol and Melitracen Tablets 1 records · Latest accepted 2026/11/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602677 | Generic | 2026/11/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/10/09
Generic · 2
No verified English name 1 records · Latest accepted 2026/08/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601581 | Supplement | 2026/08/21 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Letermovir Tablets 4 records · Latest accepted 2026/08/11
Supplement · 3Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601529 | Supplement | 2026/08/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2502432 | Supplement | 2025/11/28 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501384 | Supplement | 2025/07/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201815 | Generic | 2022/10/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Letermovir Injection 4 records · Latest accepted 2026/08/10
Supplement · 3Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601516 | Supplement | 2026/08/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2502454 | Supplement | 2025/12/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501391 | Supplement | 2025/07/12 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2202069 | Generic | 2022/12/13 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 6 records · Latest accepted 2026/06/26
Supplement · 3Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601201 | Supplement | 2026/06/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601200 | Supplement | 2026/06/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601199 | Supplement | 2026/06/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101755 | Generic | 2021/09/18 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101754 | Generic | 2021/09/18 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101753 | Generic | 2021/09/18 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/06/22
Generic · 2
Nafamostat Mesilate for Injection 2 records · Latest accepted 2026/06/10
Generic · 2
Axitinib Tablets 1 records · Latest accepted 2026/06/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601231 | Generic | 2026/06/01 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2601666 | Supplement | 2026/04/28 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/04/24
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600949 | Generic | 2026/04/24 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2504228 | Generic | 2025/12/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400185 | Generic | 2024/09/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400131 | Generic | 2024/06/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600946 | Generic | 2026/04/24 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Levetiracetam in Sodium Chloride Injection 2 records · Latest accepted 2026/04/11
Generic · 2
No verified English name 1 records · Latest accepted 2026/04/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2601391 | Supplement | 2026/04/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Apalutamide Tablets 2 records · Latest accepted 2026/04/01
Generic · 2
No verified English name 1 records · Latest accepted 2026/03/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2601089 | Supplement | 2026/03/27 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Sitagliptin and Metformin Hydrochloride Extended-release Tablets 2 records · Latest accepted 2026/03/05
Supplement · 2
Regorafenib Tablets 2 records · Latest accepted 2026/01/20
Supplement · 1Generic · 1
Ramelteon Tablets 2 records · Latest accepted 2026/01/10
Generic · 2
No verified English name 3 records · Latest accepted 2026/01/06
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600015 | New drug | 2026/01/06 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Zhongguo Yao Ke University romanized | CDE ↗ |
| CXHL2600014 | New drug | 2026/01/06 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Zhongguo Yao Ke University romanized | CDE ↗ |
| CXHL2600013 | New drug | 2026/01/06 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Zhongguo Yao Ke University romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/09/10
Supplement · 2
Pirarubicin Hydrochloride for Injection 1 records · Latest accepted 2025/09/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503252 | Generic | 2025/09/04 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Acetaminophen Sustained-release Tablets 1 records · Latest accepted 2025/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503190 | Generic | 2025/08/30 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Elagolix Sodium Tablets 6 records · Latest accepted 2025/08/09
Generic · 4Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502892 | Generic | 2025/08/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2502891 | Generic | 2025/08/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400521 | Supplement | 2024/04/23 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400520 | Supplement | 2024/04/23 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2200108 | Generic | 2022/12/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2200107 | Generic | 2022/12/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/07/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501495 | Supplement | 2025/07/28 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Fruquintinib Capsules 2 records · Latest accepted 2025/07/24
Generic · 2
No verified English name 2 records · Latest accepted 2025/07/12
Generic · 2
No verified English name 1 records · Latest accepted 2025/07/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502429 | Generic | 2025/07/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/07/08
Generic · 2
Chidamide Tablets 1 records · Latest accepted 2025/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502136 | Generic | 2025/06/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Acetylcysteine Injection 2 records · Latest accepted 2025/06/12
Generic · 2
Ioversol Injection 2 records · Latest accepted 2025/05/17
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501798 | Generic | 2025/05/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Sichuan Hui Yu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2501797 | Generic | 2025/05/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Sichuan Hui Yu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Iopromide Injection 2 records · Latest accepted 2025/05/16
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500989 | Supplement | 2025/05/16 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2500988 | Supplement | 2025/05/16 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/05/08
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500357 | New drug | 2025/05/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500356 | New drug | 2025/05/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2300015 | New drug | 2023/01/06 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Pemafibrate Tablets 1 records · Latest accepted 2025/04/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501531 | Generic | 2025/04/23 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/04/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501515 | Generic | 2025/04/22 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/04/09
Generic · 2
Methylthioninium Chloride Enteric-coated Sustained-Release Tablets 1 records · Latest accepted 2025/04/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501234 | Generic | 2025/04/01 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/03/04
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500197 | New drug | 2025/03/04 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/02/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500851 | Generic | 2025/02/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Perflutren Lipid Microsphere Injection 1 records · Latest accepted 2025/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500157 | Generic | 2025/01/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Safinamide Methansulfonate Tablets 2 records · Latest accepted 2024/12/21
Generic · 2
No verified English name 4 records · Latest accepted 2024/11/08
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401199 | New drug | 2024/11/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2401198 | New drug | 2024/11/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400499 | New drug | 2024/05/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400498 | New drug | 2024/05/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Avatrombopag Maleate Tablets 2 records · Latest accepted 2024/10/11
Supplement · 1Generic · 1
No verified English name 1 records · Latest accepted 2024/09/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403274 | Generic | 2024/09/27 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Succinylated Gelatin Injection 2 records · Latest accepted 2024/09/14
Generic · 2
Mirogabalin Besilate Tablets 1 records · Latest accepted 2024/08/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402456 | Generic | 2024/08/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Rivaroxaban Tablets 1 records · Latest accepted 2024/08/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401164 | Supplement | 2024/08/01 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Obeticholic Acid Tablets 2 records · Latest accepted 2024/07/02
Generic · 2
Deutetrabenazine Tablets 3 records · Latest accepted 2024/05/09
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401378 | Generic | 2024/05/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2401377 | Generic | 2024/05/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2401376 | Generic | 2024/05/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2024/05/08
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400432 | New drug | 2024/05/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400431 | New drug | 2024/05/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400430 | New drug | 2024/05/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Pamidronate Disodium Injection 3 records · Latest accepted 2024/04/17
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401138 | Generic | 2024/04/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2401137 | Generic | 2024/04/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2401136 | Generic | 2024/04/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Ibrutinib Capsules 1 records · Latest accepted 2024/02/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400607 | Generic | 2024/02/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Glycerol Fructose And Sodium Chloride Injection 2 records · Latest accepted 2024/01/31
Supplement · 2
No verified English name 2 records · Latest accepted 2023/12/09
Supplement · 2
No verified English name 1 records · Latest accepted 2023/09/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302411 | Generic | 2023/09/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Ziprasidone Mesylate for Injection 1 records · Latest accepted 2023/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302315 | Generic | 2023/08/30 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Palbociclib Tablets 2 records · Latest accepted 2023/08/02
Generic · 2
No verified English name 4 records · Latest accepted 2023/07/11
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300761 | New drug | 2023/07/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300760 | New drug | 2023/07/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2101108 | New drug | 2021/05/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2101107 | New drug | 2021/05/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/05/22
Generic · 2
Dapagliflozin And Metformin Hydrochloride Extended-Release Tablets 2 records · Latest accepted 2023/02/14
Generic · 2
Tafamidis Meglumine Soft Capsules 1 records · Latest accepted 2023/02/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300396 | Generic | 2023/02/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Indocyaninegreen for Injection 1 records · Latest accepted 2023/01/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300225 | Generic | 2023/01/29 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Lanthanum Carbonate Chewable Tablets 2 records · Latest accepted 2023/01/11
Supplement · 1Generic · 1
Sugammadex Sodium Injection 2 records · Latest accepted 2022/12/29
Generic · 2
Dabigatran Etexilate Capsules 2 records · Latest accepted 2022/11/21
Generic · 2
No verified English name 4 records · Latest accepted 2022/10/10
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200773 | New drug | 2022/10/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200772 | New drug | 2022/10/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200771 | New drug | 2022/10/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200770 | New drug | 2022/10/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Ruxolitinib Phosphate Tablets 3 records · Latest accepted 2022/07/14
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201058 | Generic | 2022/07/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201057 | Generic | 2022/07/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201056 | Generic | 2022/07/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Iopamidol Injection 1 records · Latest accepted 2022/06/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200983 | Supplement | 2022/06/16 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Argatroban Injection 2 records · Latest accepted 2022/04/18
Supplement · 2
Tadalafil Tablets 3 records · Latest accepted 2022/03/02
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2240006 | Supplement | 2022/03/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2240005 | Supplement | 2022/03/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2240004 | Supplement | 2022/03/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin Tablets 2 records · Latest accepted 2021/12/23
Generic · 2
Polidocanol Injection 3 records · Latest accepted 2021/11/09
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101641 | Generic | 2021/11/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101640 | Generic | 2021/08/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101639 | Generic | 2021/08/26 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/09/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101825 | Supplement | 2021/09/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Edoxaban Tosilate Tablets 3 records · Latest accepted 2021/08/25
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101634 | Generic | 2021/08/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101633 | Generic | 2021/08/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101632 | Generic | 2021/08/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Tedizolid Phosphate Tablets 1 records · Latest accepted 2021/08/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101493 | Generic | 2021/08/03 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Tedizolid Phosphate For Injection 1 records · Latest accepted 2021/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101263 | Generic | 2021/06/04 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Moxifloxacin Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2021/04/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150549 | Supplement | 2021/04/23 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Pantoprazole Sodium For Injection 1 records · Latest accepted 2021/01/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150080 | Supplement | 2021/01/29 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
13 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 5 applicationsNo longer listed under review: 6 applicationsSupplement delivery: 2 applications
- 2026/11/05No longer listed under review
No verified English name
CYHS2501342
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2025/04/09
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/05No longer listed under review
No verified English name
CYHS2501341
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2025/04/09
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/05Accepted
Imrecoxib Tablets
CYHS2602700
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/11/04No longer listed under review
No verified English name
CYHS2502429
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2025/07/09
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/02Accepted
Flupentixol and Melitracen Tablets
CYHS2602677
Fact date: 2026/11/02 · Site observation date: 2026/11/03
View source ↗ - 2026/10/31No longer listed under review
Letermovir Tablets
CYHB2601529
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/08/11
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 12
NMPA · Table row 12 ↗ View source ↗ - 2026/10/30No longer listed under review
Letermovir Injection
CYHB2601516
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2026/08/10
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/28); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 7
NMPA · Table row 7 ↗ View source ↗ - 2026/10/29Supplement delivery
Letermovir Tablets
CYHB2601529
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 12 ↗ - 2026/10/28Supplement delivery
Letermovir Injection
CYHB2601516
Fact date: 2026/10/28 · Publication date: 2026/10/29 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 7 ↗ - 2026/10/28No longer listed under review
Chidamide Tablets
CYHS2502136
Fact date: 2026/10/28 · Site observation date: 2026/10/28
Accepted: 2025/06/14
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/09Accepted
No verified English name
CYHS2602468
Fact date: 2026/10/09 · Site observation date: 2026/10/21
View source ↗ - 2026/10/09Accepted
No verified English name
CYHS2602467
Fact date: 2026/10/09 · Site observation date: 2026/10/21
View source ↗ - 2026/08/21Accepted
No verified English name
CYHB2601581
Fact date: 2026/08/21 · Site observation date: 2026/10/21
View source ↗
Under review
36 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Imrecoxib Tablets | CYHS2602700 | Generic | 2026/11/05 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Flupentixol and Melitracen Tablets | CYHS2602677 | Generic | 2026/11/02 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2602468 | Generic | 2026/10/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2602467 | Generic | 2026/10/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2601581 | Supplement | 2026/08/21 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2601462 | Generic | 2026/06/22 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2601461 | Generic | 2026/06/22 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Nafamostat Mesilate for Injection | CYHS2601358 | Generic | 2026/06/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Nafamostat Mesilate for Injection | CYHS2601357 | Generic | 2026/06/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Axitinib Tablets | CYHS2601231 | Generic | 2026/06/01 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2600949 | Generic | 2026/04/24 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2600946 | Generic | 2026/04/24 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Levetiracetam in Sodium Chloride Injection | CYHS2600834 | Generic | 2026/04/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Levetiracetam in Sodium Chloride Injection | CYHS2600833 | Generic | 2026/04/11 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Apalutamide Tablets | CYHS2600764 | Generic | 2026/04/01 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Regorafenib Tablets | CYHB2600098 | Supplement | 2026/01/20 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Ramelteon Tablets | CYHS2600136 | Generic | 2026/01/10 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Pirarubicin Hydrochloride for Injection | CYHS2503252 | Generic | 2025/09/04 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Acetaminophen Sustained-release Tablets | CYHS2503190 | Generic | 2025/08/30 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Elagolix Sodium Tablets | CYHS2502892 | Generic | 2025/08/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Elagolix Sodium Tablets | CYHS2502891 | Generic | 2025/08/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Fruquintinib Capsules | CYHS2502686 | Generic | 2025/07/24 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Fruquintinib Capsules | CYHS2502685 | Generic | 2025/07/24 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2502498 | Generic | 2025/07/12 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2502497 | Generic | 2025/07/12 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2502421 | Generic | 2025/07/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2502420 | Generic | 2025/07/08 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Acetylcysteine Injection | CYHS2502107 | Generic | 2025/06/12 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Methylthioninium Chloride Enteric-coated Sustained-Release Tablets | CYHS2501234 | Generic | 2025/04/01 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Perflutren Lipid Microsphere Injection | CYHS2500157 | Generic | 2025/01/09 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2201058 | Generic | 2022/07/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2201057 | Generic | 2022/07/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2201056 | Generic | 2022/07/14 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Edoxaban Tosilate Tablets | CYHS2101634 | Generic | 2021/08/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Edoxaban Tosilate Tablets | CYHS2101633 | Generic | 2021/08/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
| Edoxaban Tosilate Tablets | CYHS2101632 | Generic | 2021/08/25 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
92 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Sitagliptin and Metformin Hydrochloride Extended-release Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20269199 | 2026/08/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mirogabalin Besilate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20263603 | 2026/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pamidronate Disodium Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20256436 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pamidronate Disodium Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20256437 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Deutetrabenazine Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20255864 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Deutetrabenazine Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20255866 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Deutetrabenazine Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20255865 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ibrutinib Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20254986 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20254017 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glycerol Fructose And Sodium Chloride Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20043329 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Glycerol Fructose And Sodium Chloride Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20043328 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249731 | 2024/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ziprasidone Mesylate for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249753 | 2024/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249732 | 2024/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249466 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249467 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249528 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249529 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Indocyaninegreen for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249047 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Letermovir Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20249025 | 2024/10/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dabigatran Etexilate Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20244962 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dabigatran Etexilate Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20244963 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tafamidis Meglumine Soft Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20244162 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243914 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243915 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sugammadex Sodium Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243935 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sugammadex Sodium Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243936 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243916 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Letermovir Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243449 | 2024/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20183077 | 2023/11/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20183076 | 2023/11/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Macitentan Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20234258 | 2023/10/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20234191 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Polidocanol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233934 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Polidocanol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233935 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Polidocanol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233936 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233802 | 2023/06/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pazopanib Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233257 | 2023/03/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Regorafenib Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233172 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Argatroban Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20237006 | 2023/01/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tedizolid Phosphate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223959 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate For Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223944 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dexrazoxane for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223884 | 2022/11/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lanthanum Carbonate Chewable Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223690 | 2022/09/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mirabegron Extended-release Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223097 | 2022/03/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20227005 | 2022/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sitagliptin and Metformin Hydrochloride Extended-release Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213961 | 2021/12/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203073 | 2021/12/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Raltitrexed for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20090325 | 2021/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sitagliptin Phosphate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213682 | 2021/09/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213683 | 2021/09/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pantoprazole Sodium For Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20205034 | 2021/08/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tadalafil Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20217072 | 2021/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20217071 | 2021/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sofosbuvir Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213643 | 2021/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenvatinib Mesilate Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213638 | 2021/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amlodipine Besylate and Atorvastatin Calcium Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213611 | 2021/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aprepitant Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213561 | 2021/06/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aprepitant Capsules | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213560 | 2021/06/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213542 | 2021/06/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tolvaptan Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20213392 | 2021/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iodixanol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20183201 | 2021/04/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20093403 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20093404 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ticagrelor Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20205020 | — | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Parecoxib Sodium for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20183465 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20183464 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olmesartan Medoxomil and Amlodipine Besylate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203643 | 2020/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pantoprazole Sodium For Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20083743 | 2020/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pantoprazole Sodium For Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20083742 | 2020/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bortezomib For Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20183401 | 2020/10/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bortezomib For Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20194084 | 2020/10/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080669 | 2020/08/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203354 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tofacitinib Citrate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203348 | 2020/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apixaban Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203336 | 2020/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Idarubicin Hydrochloride for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203345 | 2020/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Idarubicin Hydrochloride for Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203344 | 2020/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203293 | 2020/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20203269 | 2020/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ticagrelor Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20193177 | 2019/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20193187 | 2019/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | 2017/12/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20263565 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pamidronate Disodium Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20256435 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Avatrombopag Maleate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20234563 | 2023/11/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20217073 | 2021/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Safinamide Methansulfonate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20266029 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Safinamide Methansulfonate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20266030 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ioversol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Sichuan Hui Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20265800 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ioversol Injection | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Sichuan Hui Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20265801 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pemafibrate Tablets | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20266053 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
8 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20220000415 | I | 2022/06/20 | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20190000665 | I | 2019/08/02 | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20190000052 | I | 2019/03/01 | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20170001381 | I | — | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20170001374 | I | — | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20170001207 | I | — | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20170000923 | I | — | CDE ↗ |
| No verified English name | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Y20170000551 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.